Senior Research Officer

  • Based in Herston, Brisbane
  • 2 year full-time appointment
  • Attractive salary packaging & superannuation options

About QIMR Berghofer:

QIMR Berghofer is a world-leading translational medical research institute focused on improving health by developing new diagnostics, better treatments and prevention strategies, specifically in the areas of cancer, infectious diseases, mental health and complex disorders. Based in Herston, Brisbane and working in close collaboration with clinicians and other research institutes, QIMR Berghofer is home to more than 600 scientists, students and support staff.

About the team:

The applicant will join a large international team of tumor immunologists and cancer biologists (>20 staff and students). QIMR Berghofer Medical Research Institute provides world class facilities for histology, flow cytometry, imaging and animal experiments. The Microscopy Facility at QIMR Berghofer is part of the Flow Cytometry and Imaging Facility, which is headed by Grace Chojnowski, and operated by Nigel Waterhouse and Tam Hong Nguyen. The facility utilizes a Perkin Elmer Vectra automated quantitative pathology system for fluorescent slide scanning and spectral unmixing.

Role Purposes / Responsibilities:

The applicant is expected to have a strong track record in use of microscopy and imaging for biomarker analysis of human tissues and a strong understanding of immunology and the tumor microenvironment. The SRO will work in an interactive team environment comprised of a group leader, Dr. Bill Dougall and other ROs and RAs to study novel targets for cancer immunotherapy. The objectives for this position are to apply spatially-resolved microenvironment profiling (e.g. multiplex IHC) of human tumor samples and integrate these findings with other research in the lab (eg gene expression profiling, flow cytometry, experimental pharmacology) to define new targets or modifiers of immunotherapy response. The following duties will apply:

  • The candidate will serve generally as a domain expert in multiparameter analyses of immuno-oncology biomarkers for the team.
  • The candidate will implement the multiplex IHC platform by facilitating research collaborations, experimental design, experimental execution and data analysis.
  • The candidate will be expected to contribute to publications, invention disclosures, as needed, to a publishable standard.
  • Ideally, the candidate will generate biological hypotheses (e.g., patient selection, drug combinations, new targets) in various oncology settings arising from interpretation of biomarker data.
  • Clearly communicate data and interpretations to group leader and rest of the team.
  • Management of staff, students

About You:

The successful Applicant is expected to have technical knowledge and experience in:

  • Extensive hands-on laboratory experience with molecular medicine technologies such as multi-parameter immune profiling (flow cytometry, CyTOF) or multiplex IHC, and experience interpreting data from such analyses.
  • Track record in leading innovative efforts to deploy novel technologies and assays for analysis of human tissues.
  • Proven scientific track record documented by publications in high-ranking journals.
  • Team leader and team player with strong people skills. Ability to work independently but also in a collaborative manner with local teams.
  • Excellent communication and presentation skills.
  • Strong analytical skills for integrating and interpreting interdisciplinary data.
  • MSc and/or PhD in a relevant field (Pathology, Immunology, Oncology Research or Molecular Biology preferred), with at least 3 years of relevant post graduate experience.

What we offer:

  • Salary Packaging
  • Bonus Superannuation
  • State of the art facilities
  • Stimulating work setting focussed on cutting edge medical research
  • Supportive/collaborative team environment

This is a two-year appointment with strong prospect of renewal. The salary level will be commensurate with the applicant’s experience. The successful candidate can expect to commence the position anytime up to October 15, 2017.

Click on the “Apply” button on the positions vacant page.

Applications should address the selection criteria and include curriculum vitae, proof of qualifications, and the names and contact details of three professional referees.

01 October 2017
Contact Professor Mark Smyth or or Dr. Bill Dougall: